Navigation Links
Reportlinker Adds Biomarkers: Technologies and Global Markets
Date:5/3/2011

NEW YORK, May 3, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Biomarkers: Technologies and Global Markets

http://www.reportlinker.com/p0488647/Biomarkers-Technologies-and-Global-Markets.html

In 2010, the total global market for biomarkers was an estimated $13.5 billion and is expected to grow to nearly $33.3 billion by the end of 2015 at a 5-year compound annual growth rate (CAGR) of 19.8%.

Of all segments, genomics will continue as the largest, at 2010 revenue of $5.1 billion, growing to $16.9 billion in 2015, a compound annual growth rate (CAGR) of 26.9%. Genomics has been and will continue to be the fastest-growing driver of biomarker technology.

Imaging, as a modality, completed 2010 with $4.2 billion in revenue. The next 5 years will continue to see growth, slightly outpacing proteomics, at a 14.8% compound annual growth rate (CAGR) from 2010 to 2015 to reach a value of $8.4 million in 2015. 

INTRODUCTION

STUDY GOALS AND OBJECTIVES

This study provides a comprehensive analysis of biomarkers on a global basis. Its aim is to provide a range of information, from detailed product analyses within disease subsegments to overall industry trends, in order to quantify and qualify the market for products and services in the biomarkers segment. Individual product-types are forecast on a global basis, as are overall segments. Forecasts and trends are developed from a cross-reference of data points, gleaned from proprietary industry sources, company publications, industry benchmarking, and other divergent data sources to arrive at a cogent and coordinated forecast.

REAS
'/>"/>

SOURCE MDX
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Reportlinker Adds Medical Enzymes: Technologies and Global Markets
2. Reportlinker Adds Case Study: Personalized Cancer Therapy - The era of biomarker identification and companion diagnostic co-development
3. Reportlinker Adds R&D Trends: Osteoporosis - Strong pipeline bodes well for future treatment
4. Reportlinker Adds Molecular Diagnostics Market: DNA Probes And Biochips
5. Reportlinker Adds Competitor Analysis: Targeted Therapy of Diabetes
6. Reportlinker Adds China Bio-breeding Industry Report, 2010
7. Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other
8. Reportlinker Adds Biomarker Partnering Terms and Agreements
9. Reportlinker Adds Top & Emerging Bio-Fuel Markets by Technology, Feedstocks, Regulations, Pricing & Commercialization Trends & Forecasts (2011 - 2016)
10. Reportlinker Adds Industrial Biotechnology China News 1103
11. Reportlinker Adds DNA Sequencing - Technologies, Markets and Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Dec. 23, 2014 Sigma-Aldrich Corporation (NASDAQ: ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... on December 22, 2014, thereby completing the U.S. ... the acquisition of the Company by Merck KGaA, ... satisfies another condition to closing the transaction, which ...
(Date:12/22/2014)... Malvern, PA & Brussels (PRWEB) December 22, 2014 ... Education (CfPIE), the global leader of technical training ... Society for Clinical Data Management (SCDM) to ... training and certification programs —providing access to the ... The partnership extends SCDM members with 10% off when ...
(Date:12/22/2014)... HILL, N.C. , Dec. 22, 2014 /PRNewswire/ ... today announced that it has signed a letter ... company that has developed and patented a nanotechnology-based ... medical diagnostics products that enable rapid on-site collection ... alcohol use/abuse and health issues in an immediate, ...
(Date:12/22/2014)... December 22, 2014 The ... publication of original research, reviews and editorials addressing ... clinical practice, today published a provocative article exploring ... development, progression and potential treatment of prostate cancer. ... research and proposes the possibility that there could ...
Breaking Biology Technology:Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3CfPIE Announces Partnership with the Society for Clinical Data Management 2CfPIE Announces Partnership with the Society for Clinical Data Management 3ALNE Announces Intention To Acquire BioTechPharma 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4
... , , CAMBRIDGE, ... ), a biopharmaceutical company engaged in the discovery and development of ... pricing of an underwritten offering of 7,248,936 shares of its common ... and commissions and estimated offering expenses, the company expects to receive ...
... , , SAN DIEGO, Aug. 5 ... will provide partial funds for long-term follow-up testing of patients enrolled ... The funding will enable Ceregene to collect and analyze more ... Parkinson,s disease who were enrolled in the double-blind, controlled trial which ...
... Mass., Aug. 5 NxStage Medical, Inc. (Nasdaq: NXTM ... revenue for the second quarter of 2009 of $36.4 million, an ... for the second quarter of 2008. , , ... in Home, solid machine sales in Critical Care, and continued progress ...
Cached Biology Technology:Idenix Pharmaceuticals Prices Underwritten Offering of Common Stock 2Ceregene Receives Additional Grant From Michael J. Fox Foundation to Expand Long-Term Testing of CERE-120 Patients 2Ceregene Receives Additional Grant From Michael J. Fox Foundation to Expand Long-Term Testing of CERE-120 Patients 3Ceregene Receives Additional Grant From Michael J. Fox Foundation to Expand Long-Term Testing of CERE-120 Patients 4NxStage Reports Second Quarter 2009 Financial Results 2NxStage Reports Second Quarter 2009 Financial Results 3NxStage Reports Second Quarter 2009 Financial Results 4NxStage Reports Second Quarter 2009 Financial Results 5NxStage Reports Second Quarter 2009 Financial Results 6NxStage Reports Second Quarter 2009 Financial Results 7NxStage Reports Second Quarter 2009 Financial Results 8NxStage Reports Second Quarter 2009 Financial Results 9NxStage Reports Second Quarter 2009 Financial Results 10NxStage Reports Second Quarter 2009 Financial Results 11NxStage Reports Second Quarter 2009 Financial Results 12
(Date:12/3/2014)... 2014 As part of our commitment to ... pleased to announce the release of a new reader ... the workforce data that they need. The ... by existing readers. Many such devices have serious shortcomings ... technology. Older models force users to navigate numerous complicated ...
(Date:11/21/2014)... YORK , Nov. 19, 2014  Earlier this ... at New York College, and one of the most ... biosensor signals that are transmitted from Smartphones to third ... were Smartphones and has one of the earliest known ... discussing its usage in the military, child care, elder ...
(Date:11/21/2014)... -- C-Labs LLC, a leading provider of remote and ... announced the appointment of John Traynor to ... advisor to the firm, Mr. Traynor will now oversee ... out of the C-Labs office in Redmond, ... , Chief Executive Officer. Photo - ...
Breaking Biology News(10 mins):Inception Technologies to Release New Biometric Reader 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2
... pleased to announce the 2010 Yeast Genetics and Molecular ... of British Columbia (UBC) in Vancouver, Canada. This ... eukaryotic biology in yeast. Program highlights include presentations ... is also a Member of Parliament. The ...
... discovered a key reason why a form of leukemia ... phase called blast crisis. The study, led by cancer ... G. James Cancer Hospital and Richard J. Solove Research ... when immature white blood cells lose a molecule called ...
... Diego, paleoceanographer Richard Norris is one of 41 scientists presenting ... and myriad other organisms 30 years after the theory was ... paper being released Friday in the journal Science ... the cause of the mass extinction. Norris, contribution to the ...
Cached Biology News:2010 Yeast Genetics and Molecular Biology Meeting 22010 Yeast Genetics and Molecular Biology Meeting 3Study identifies key cause of chronic leukemia progression 230 years later, what killed the dinosaurs is revisited 230 years later, what killed the dinosaurs is revisited 3
Rab 3 Immunogen: Synthetic peptide corresponding to the N-terminal region of Rab 3 protein. Storage: -20 C, Avoid Freeze/Thaw Cycles...
... Disrupts biological cells for DNA ... 96 well plates (includes 96 well ... consistent lysis across the entire plate ... wells). Can be used for ...
Request Info...
GBL Antibody...
Biology Products: